Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00351403
Show Display Options
Rank Status Study
1 Completed Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Ribavirin;   Drug: Peginterferon alfa 2b

Indicates status has not been verified in more than two years